Biohaven Ltd.
BHVN
$8.17
-$0.20-2.39%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -7.43% | 37.22% | 44.22% | 24.60% | 18.84% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -44.34% | -4.93% | 30.78% | 20.91% | 23.56% |
| Operating Income | 44.34% | 4.93% | -30.78% | -20.91% | -23.56% |
| Income Before Tax | 22.27% | -8.02% | 38.08% | -23.55% | -27.97% |
| Income Tax Expenses | 631.25% | 474.58% | 47.46% | 7.03% | 103.96% |
| Earnings from Continuing Operations | 22.10% | -8.20% | 38.03% | -23.49% | -29.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 22.10% | -8.20% | 38.03% | -23.49% | -29.07% |
| EBIT | 44.34% | 4.93% | -30.78% | -20.91% | -23.56% |
| EBITDA | 44.98% | 5.63% | -31.14% | -20.64% | -23.48% |
| EPS Basic | 34.50% | 3.50% | 46.88% | 1.15% | -2.09% |
| Normalized Basic EPS | 51.66% | 5.10% | -13.36% | 1.59% | -0.67% |
| EPS Diluted | 34.50% | 3.50% | 46.88% | 1.15% | -2.09% |
| Normalized Diluted EPS | 51.66% | 5.10% | -13.36% | 1.59% | -0.67% |
| Average Basic Shares Outstanding | 18.93% | 12.13% | 16.64% | 24.93% | 26.43% |
| Average Diluted Shares Outstanding | 18.93% | 12.13% | 16.64% | 24.93% | 26.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |